From phytochemical prioritization to cell-based validation: tricoumaroyl spermidine from Agrimonia eupatoria displays cell-context-dependent antiproliferative activity associated with PI3K/AKT/mTOR-HIF-1α signaling
Background Agrimonia eupatoria L. is a medicinal plant with reported anticancer activity. Tricoumaroyl spermidine (TCS), a major constituent of its ethanolic extract (AEE), was previously identified as a potential regulator of PI3K signaling based on phytochemical and computational analyses. However, the biological activity of isolated TCS has not been experimentally validated. This study investigated the anticancer effects of purified TCS using AEE as a botanical comparator. Methods The effects of AEE and TCS were evaluated in MCF-7 and MDA-MB-231 breast cancer cells by endpoint viability assays, real-time impedance monitoring, fluorescence-based live/dead cell imaging, and quantitative analysis of live and dead cell populations. The effects of TCS on breast cancer cell migration were assessed in MDA-MB-231 cells. Immunocytochemistry was performed to evaluate pPI3K, pAKT, mTOR, HIF-1α, and Caspase-3 expression in insulin- and CoCl₂-stimulated A549 and MDA-MB-231 cells. Molecular docking, protein-protein interaction, and KEGG pathway enrichment analyses were performed to identify potential molecular targets and associated signaling pathways. Results AEE reduced the viability of MCF-7 cells in a time- and concentration-dependent manner, whereas MDA-MB-231 cells were comparatively less sensitive in endpoint assays. TCS decreased cell proliferation and increased the proportion of membrane-compromised cells in MCF-7 cultures. In MDA-MB-231 cells, AEE significantly reduced proliferation, whereas TCS had little effect on proliferation but significantly inhibited cancer cell migration and increased the proportion of membrane-compromised cells. Under insulin/hypoxic stimulation, TCS reduced pPI3K, pAKT, mTOR, and HIF-1α immunofluorescence signals while increasing Caspase-3 staining. Molecular docking predicted the strongest binding of TCS to COX-2 and AKT, and pathway enrichment analysis linked the candidate targets to apoptosis, PI3K/Akt, HIF-1, p53, autophagy, VEGF, TNF, JAK/STAT, MAPK, and mTOR signaling. Conclusions TCS exhibited anticancer activity with distinct effects depending on the breast cancer cell type, suppressing proliferation in MCF-7 cells and inhibiting migration in MDA-MB-231 cells. The computational and immunocytochemical findings support the involvement of PI3K/AKT/mTOR/HIF-1α-associated signaling, although direct target engagement remains to be confirmed. These findings identify TCS as a promising natural-product lead for further mechanistic and in vivo studies.
Authors
- Alina Maloyan (ORCID: https://orcid.org/0000-0002-7309-5026)
- Meri Kocharyan (ORCID: https://orcid.org/0009-0009-7676-5038)
- Arpine Hakobyan
- Avtandilyan Nikolay
- Hayarpi Javrushyan
- Aqsanna Gevorgyan
- Mikayel Ginovyan
Institutions
- Oregon Health & Science University (US)
- Yerevan State University (AM)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-10594229/v1
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- preprint